| Inhibition of mTORC1/2 overcomes resistance to MAPK pathway inhibitors mediated by PGC1α and oxidative phosphorylation in melanoma YNV Gopal, H Rizos, G Chen, W Deng, DT Frederick, ZA Cooper, ... Cancer research 74 (23), 7037-7047, 2014 | 95 | 2014 |
| Molecular profiling of patient-matched brain and extracranial melanoma metastases implicates the PI3K pathway as a therapeutic target G Chen, N Chakravarti, K Aardalen, AJ Lazar, MT Tetzlaff, B Wubbenhorst, ... Clinical Cancer Research 20 (21), 5537-5546, 2014 | 90 | 2014 |
| RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma L Goedert, CG Pereira, J Roszik, JR Plaça, C Cardoso, G Chen, W Deng, ... Oncotarget 7 (24), 36711, 2016 | 21 | 2016 |
| Different isolates from Leishmania braziliensis complex induce distinct histopathological features in a murine model of infection CG Pereira, ALN Silva, P de Castilhos, EC Mastrantonio, RA Souza, ... Veterinary parasitology 165 (3-4), 231-240, 2009 | 19 | 2009 |
| Ten years of iPSC: clinical potential and advances in vitro hematopoietic differentiation BCMF Paes, PD Moço, CG Pereira, GS Porto, EM de Sousa Russo, ... Cell biology and toxicology 33 (3), 233-250, 2017 | 18 | 2017 |
| Novel primate-specific genes, RMEL 1, 2 and 3, with highly restricted expression in melanoma, assessed by new data mining tool JF Sousa, R Torrieri, RR Silva, CG Pereira, V Valente, E Torrieri, ... PloS one 5 (10), 2010 | 18 | 2010 |
| A typical presentation of cutaneous leishmaniasis after renal transplantation FA Vinhal, SR Afonso-Cardoso, AG Silva, CG Pereira, W Sousa, ... Nephrology Dialysis Transplantation 22 (12), 3674-3674, 2007 | 10 | 2007 |
| Patent mining and landscaping of emerging recombinant factor VIII through network analysis CG Pereira, V Picanco-Castro, DT Covas, GS Porto Nature biotechnology 36 (7), 585-590, 2018 | 9 | 2018 |
| Effects of Bothrops moojeni venom on Leishmania amazonensis promastigote forms P Castilhos, CG Pereira, ALN Silva, DR Napolitano, F Oliveira, MA Souza Journal of Venomous Animals and Toxins including Tropical Diseases 17 (2 …, 2011 | 7 | 2011 |
| Uncovering innovation features and emerging technologies in molecular biology through patent analysis CG Pereira, GS Porto Recombinant Glycoprotein Production, 15-34, 2018 | 5 | 2018 |
| The scientific information provided through patents and its limited use in scientific research at universities CG Pereira, RR Da Silva, GS Porto Brazilian Journal of Science and Technology 2 (1), 2, 2015 | 5 | 2015 |
| Technological cooperation network in biotechnology CG Pereira, RR Da Silva, JR Lavoie, GS Porto Innovation & Management Review, 2018 | 4 | 2018 |
| Forecasting of emerging therapeutic monoclonal antibodies patents based on a decision model CG Pereira, JR Lavoie, E Garces, F Basso, M Dabić, GS Porto, T Daim Technological Forecasting and Social Change 139, 185-199, 2019 | 3 | 2019 |
| The lncRNA RMEL3 protects immortalized cells from serum withdrawal‐induced growth arrest and promotes melanoma cell proliferation and tumor growth C Cardoso, RB Serafim, A Kawakami, C Gonçalves Pereira, J Roszik, ... Pigment cell & melanoma research 32 (2), 303-314, 2019 | 2 | 2019 |
| Reatividade sorológica de cães frente a antígenos de três espécies de Leishmania MM Tannus, FH RODRIGUES, E CÉSAR, FAR MASTRANTONIO, ... Horizonte Científico, 11-28, 2007 | 2 | 2007 |
| The involvement of heparin in retinal infection by Toxoplasma gondii in a chick model revealed an ontogenetic-dependent pattern EC Mastrantonio, CD Lopes, CG Pereira, NM Silva, BB Fonseca, ... Parasitology international 63 (2), 337-340, 2014 | 1 | 2014 |
| Effects of energy nutritional levels on performance and egg quality of European quails in the initial laying phase SL de Toledo Barreto, BJ de Sousa Quirino, CO Brito, RT Umigi, ... REVISTA BRASILEIRA DE ZOOTECNIA-BRAZILIAN JOURNAL OF ANIMAL SCIENCE 36 (1 …, 2007 | 1 | 2007 |
| Emerging patent landscape for non-viral vectors used for gene therapy V Picanço-Castro, CG Pereira, DT Covas, GS Porto, A Athanassiadou, ... Nature Biotechnology 38 (2), 151-157, 2020 | | 2020 |
| Emerging CAR T cell therapies: clinical landscape and patent technological routes V Picanco-Castro, C Gonçalves Pereira, K Swiech, ... Human vaccines & immunotherapeutics, 1-10, 2019 | | 2019 |
| Assessment of biotechnologies: a therapeutic monoclonal antibody emerging score CG Pereira, J Lavoie, E Garces, M Dabic, GS Porto, T Daim 2018 IEEE Technology and Engineering Management Conference (TEMSCON), 1-6, 2018 | | 2018 |
Geciane PortoFEARP/USPE-mail confirmado em usp.br
